The IPO activity in the U.S. pharma/biotech sector has had a strong showing so far this year, with 41 listings in the first half of the year, and 25 listings in the second quarter, which is almost similar to the last year's q2 biotech IPO of 24 listings.
from RTT - Biotech https://ift.tt/32nfDqR
via IFTTT
No comments:
Post a Comment